Highlights
This randomized crossover trial reveals compelling evidence that dietary protein source profoundly influences metabolic health in type 2 diabetes. The study demonstrates that a dairy-enriched diet with structured meal timing yields significant improvements across multiple domains: circadian clock gene expression increased by 1.4- to 2.2-fold, fasting glucose decreased by approximately 1.7 mmol/l, and subjective hunger and sweet craving scores reduced by 15-20% compared with a non-dairy dietary approach. These findings suggest that the timing and composition of dietary protein may constitute a modifiable factor in diabetes management through circadian regulatory mechanisms.
Background
Type 2 diabetes mellitus represents a global health challenge of considerable magnitude, affecting hundreds of millions of individuals worldwide. While pharmacological interventions continue to expand, lifestyle modifications—including dietary strategies—remain foundational to management. Recent advances in chronobiology have illuminated the bidirectional relationship between circadian rhythms and metabolic function, raising intriguing questions about how meal timing and nutrient composition interact with the body’s internal clock machinery.
The circadian clock operates through a complex transcriptional-translational feedback loop involving conserved clock genes, including BMAL1, REV-ERBα (NR1D1), CRY1, and PER1. Dysregulation of these genes has been implicated in metabolic dysfunction, obesity, and glucose intolerance. Peripheral blood mononuclear cells (PBMCs) provide an accessible window into these regulatory processes, reflecting systemic circadian adaptations. Mounting evidence suggests that dietary factors, particularly protein sources, may influence clock gene expression; however, the specific effects of dairy-derived proteins in the context of type 2 diabetes remain incompletely characterized.
This study addresses a critical knowledge gap by investigating whether a dairy-enriched diet combined with high-protein breakfast consumption and early daytime carbohydrate restriction can enhance circadian clock gene expression and improve glycemic and appetite-related outcomes in individuals with established type 2 diabetes.
Study Design
The investigation employed a randomized, open-label, crossover design conducted at the Diabetes Unit, Wolfson Medical Center, Israel. Twenty-nine individuals were screened for eligibility, with 25 participants meeting inclusion criteria (HbA1c ≥48 mmol/mol or 6.5%, treated with stable doses of oral glucose-lowering agents for at least three months or managed by diet alone). Participants were randomly assigned using simple randomization (coin flip) to one of two intervention sequences: the YesMilk diet phase followed by the NoMilk diet phase, or vice versa. Due to the open-label nature of the trial, allocation was not concealed from investigators or participants.
Each dietary phase lasted four weeks, separated by a three- to four-week washout period. The YesMilk diet incorporated dairy-based protein sources, while the NoMilk diet provided isoenergetic non-dairy protein alternatives. Both interventions included a high-protein breakfast component and restricted carbohydrate intake to the early daytime period. The primary endpoint was circadian clock gene expression in peripheral blood mononuclear cells. Secondary outcomes included glycemic indices derived from continuous glucose monitoring (CGM) and appetite scores assessed through validated questionnaires.
Of the 25 randomized participants, 13 initiated with the YesMilk diet, with all completing both phases. Among the 12 who began with the NoMilk diet, six did not complete the study, yielding 19 participants who finished both intervention phases. The study was powered for the primary outcome and registered on ClinicalTrials.gov (NCT03772067), with funding provided by the Israeli Ministry of Health.
Key Findings
The results demonstrate substantial effects of dairy-enriched dietary intervention on circadian clock gene expression in peripheral blood mononuclear cells. Compared with the NoMilk phase, the YesMilk diet produced significant upregulation of three core clock genes: BMAL1 expression increased 1.8-fold (p=0.0003), REV-ERBα (NR1D1) increased 2.2-fold (p<0.001), and CRY1 increased 1.4-fold (p=0.03). Additionally, PER1 expression showed significant between-diet differences at the four-week timepoint (p=0.01). These findings indicate that dietary protein source substantially influences circadian transcriptional activity in immune cells, potentially reflecting broader systemic effects on metabolic regulation.
Glycemic variables improved significantly under the dairy-enriched dietary condition. Fasting glucose concentrations decreased by approximately 1.7 mmol/l compared with the non-dairy phase (p<0.05). The glucose management indicator (a CGM-derived estimate of glycemic exposure) declined by 0.7%, and time in range—defined as the percentage of readings between 3.9 and 10.0 mmol/l—increased by 9% relative to baseline (p<0.05). These improvements in glycemic metrics occurred within a four-week intervention period and were observed using continuous glucose monitoring, providing objective, real-world assessment of metabolic control.
Appetite-related outcomes also favored the dairy-enriched dietary approach. Subjective hunger scores decreased by 15-20%, and sweet craving scores showed comparable reductions (p<0.05). These findings suggest that dairy protein may exert favorable effects on appetite regulation and food cravings, potentially through mechanisms involving amino acid signaling, satiety peptides, or circadian-aligned metabolic processes.
Notably, the dropout pattern warrants consideration: six of twelve participants (50%) randomized to begin with the NoMilk diet withdrew during or after that phase, compared with zero withdrawals among those starting with YesMilk. While crossover analyses included only participants completing both phases, this differential attrition raises questions about tolerability or sustainability of the non-dairy dietary approach in this population.
Expert Commentary
The findings from this trial contribute meaningfully to the emerging literature on nutritional chronobiology and its implications for diabetes management. The magnitude of clock gene upregulation—particularly the 2.2-fold increase in REV-ERBα—suggests that dairy-derived proteins may engage specific molecular pathways that influence circadian transcriptional regulation. REV-ERBα functions as a nuclear receptor that represses inflammatory gene expression and modulates metabolic processes, positioning it as a potential mechanistic link between diet, circadian function, and glucose homeostasis.
The concurrent improvements in glycemic control and appetite regulation raise important mechanistic hypotheses. Dairy proteins contain branched-chain amino acids and specific bioactive peptides that may influence insulin sensitivity, incretin secretion, and satiety signaling. The high-protein breakfast component may additionally support circadian-aligned metabolic processes, as breakfast timing has been proposed to influence peripheral clock entrainment. The early daytime carbohydrate restriction strategy further aligns nutrient intake with circadian variation in insulin sensitivity, which typically peaks in the morning and declines throughout the day.
Several limitations merit consideration when interpreting these results. The open-label design introduces potential bias in subjective outcome assessment, particularly for appetite scores. The modest sample size (19 completers) and relatively short intervention duration (four weeks per phase) limit generalizability and preclude conclusions about long-term sustainability. The differential dropout pattern, though not statistically analyzed as a formal comparison, suggests potential confounding from expectancy effects or dietary tolerability differences. Additionally, the absence of detailed dietary composition data beyond protein source categorization limits understanding of which specific dairy components (whey protein, casein, lactose, or micronutrients) drive the observed effects.
From a clinical perspective, these findings offer a promising but preliminary rationale for incorporating dairy-enriched dietary strategies into type 2 diabetes management. Healthcare practitioners might consider recommending high-protein dairy breakfast options—such as Greek yogurt, cottage cheese, or milk-based smoothies—as part of comprehensive nutritional counseling. However, individual considerations, including lactose tolerance, renal function, and personal dietary preferences, should guide implementation. The translational potential of these findings would be substantially strengthened by replication in larger, double-blind trials with extended follow-up and comprehensive metabolic phenotyping.
Conclusion
This randomized crossover trial provides evidence that a dairy-enriched diet combined with high-protein breakfast and early daytime carbohydrate restriction enhances circadian clock gene expression, improves glycemic metrics, and reduces appetite in individuals with type 2 diabetes. The coordinated improvements across molecular, metabolic, and behavioral domains suggest that dietary protein source may influence metabolic health through circadian regulatory mechanisms. While these findings require confirmation in larger, longer-term studies, they advance understanding of how specific dietary interventions might be optimized to leverage circadian biology for therapeutic benefit in metabolic disease.
The study underscores the importance of considering meal timing and nutrient composition as modifiable factors in diabetes care, moving beyond generic dietary recommendations toward personalized, chronobiology-informed nutritional strategies. Future research should elucidate the specific dairy components responsible for these effects, characterize individual factors predictive of response, and determine optimal implementation in clinical practice.
Funding and Trial Registration
This study was funded by the Israeli Ministry of Health. The trial was registered prospectively on ClinicalTrials.gov (NCT03772067). The study was conducted in accordance with ethical standards and approved by the appropriate institutional review board.
References
Tsameret S, Froy O, Matz Y, Landau Z, Twito O, Wainstein J, Avital-Cohen N, Chapnik N, Jakubowicz D. Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial. Diabetologia. 2026-01-23;69(4):1021-1034. PMID: 41578008.
